Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 118.90M | $ 96.40M | $ 119.30M | $ 128.00M | $ 109.30M |
Total Assets | $ 566.90M | $ 523.90M | $ 501.60M | $ 450.70M | $ 410.50M |
Total Debt | $ 53.20M | $ 28.90M | $ 62.10M | $ 37.90M | $ 35.20M |
Net Debt | $ -65.70M | $ -67.50M | $ -57.20M | $ -90.10M | $ -74.10M |
Total Liabilities | $ 251.30M | $ 207.50M | $ 222.70M | $ 184.50M | $ 171.00M |
Stockholders Equity | $ 315.60M | $ 316.40M | $ 278.90M | $ 266.20M | $ 239.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |